Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,593.24
(
1.33%
)
US TECH 100
23,540.00
(
1.11%
)
Dow Jones
46,312.62
(
1.61%
)
Brent Oil
97.94
(
-9.42%
)
Bitcoin
70,976.96
(
4.63%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 130333

Saturday, 11/05/2011 1:39:55 PM

Saturday, November 05, 2011 1:39:55 PM

Post# of 257269

Moreover, there’s no reason why DEB025 can’t be an effective addend to a nuke-based regimen.





Sorry I didn't make myself clear. That's what I was suggesting here.

The drug could find a market after years of nuke/riba or nuke monotherapy but I would expect this to be very limited.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today